Aerovate Therapeutics (AVTE) Stock Chart & Stock Price History $2.75 +0.09 (+3.38%) As of 10:23 AM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Aerovate Therapeutics Stock Price Performance 5 Day Performance+10.44%1 Month Performance+11.34%3 Month Performance+11.79%6 Month Performance+28.50%Year-To-Date Performance+3.77%1 Year Performance-89.10% Receive AVTE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aerovate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address AVTE Stock Chart for Monday, April, 14, 2025 AVTE Chart by TradingViewRemove Ads Aerovate Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/11/2025$2.58$2.66+3.10%$2.82$2.581.04 million shs$77.10 million04/10/2025$2.49$2.58+3.61%$2.63$2.50448,591 shs$74.78 million04/09/2025$2.51$2.49-0.80%$2.58$2.47434,568 shs$72.17 million04/09/2025$2.51$2.49-0.80%$2.58$2.47434,568 shs$72.17 million04/08/2025$2.52$2.51-0.40%$2.56$2.50199,675 shs$72.75 million04/08/2025$2.52$2.51-0.40%$2.56$2.50199,675 shs$72.75 million04/07/2025$2.49$2.52+1.20%$2.57$2.49169,652 shs$73.04 million04/04/2025$2.51$2.49-0.80%$2.58$2.4594,583 shs$72.17 million04/03/2025$2.52$2.51-0.40%$2.52$2.46110,117 shs$72.75 million04/02/2025$2.51$2.52+0.40%$2.56$2.4950,500 shs$73.04 million Get the Latest News and Ratings for AVTE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aerovate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/01/2025$2.51$2.51$2.55$2.4953,914 shs$72.75 million03/31/2025$2.53$2.51-0.79%$2.53$2.4593,845 shs$72.75 million03/28/2025$2.53$2.53$2.55$2.5063,852 shs$73.05 million03/27/2025$2.51$2.53+0.80%$2.56$2.5059,550 shs$73.05 million03/26/2025$2.51$2.51$2.53$2.5060,315 shs$72.48 million03/25/2025$2.55$2.51-1.57%$2.55$2.5178,444 shs$72.48 million03/24/2025$2.52$2.55+1.19%$2.59$2.5131,450 shs$73.63 million03/21/2025$2.50$2.52+0.80%$2.56$2.4476,512 shs$72.77 million03/20/2025$2.52$2.50-0.79%$2.56$2.5051,314 shs$72.19 million03/19/2025$2.49$2.52+1.20%$2.55$2.4951,131 shs$72.77 million03/18/2025$2.46$2.49+1.22%$2.51$2.2461,913 shs$71.90 million03/17/2025$2.47$2.46-0.40%$2.51$2.4460,056 shs$71.03 million03/14/2025$2.47$2.47$2.57$2.4347,375 shs$71.32 million03/13/2025$2.50$2.47-1.20%$2.53$2.4454,179 shs$71.32 million Related Companies Tectonic Therapeutic Stock Chart Oruka Therapeutics Stock Chart Mereo BioPharma Group Stock Chart Benitec Biopharma Stock Chart Aura Biosciences Stock Chart Cryoport Stock Chart Cartesian Therapeutics Stock Chart 2seventy bio Stock Chart Aquestive Therapeutics Stock Chart Taysha Gene Therapies Stock Chart Receive AVTE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aerovate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AVTE) was last updated on 4/14/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | SponsoredThe biggest story CNBC isn't talking about (yet)This Story Could Go Viral as Soon as May 31 Quietly, towns like Shreveport, Louisiana and Fort Worth, Texas...Stansberry Research | SponsoredCatastrophicThe losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.InvestorPlace | SponsoredTrump’s betrayal exposed Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredVolatility's Next Big Opportunity?With tariffs rattling the markets, many investors are watching helplessly… But according to legendary "Mark...Brownstone Research | SponsoredTrump 2028 could be a “bonanza” for investorsAs you may have heard, Donald Trump is planning to run for a THIRD term in 2028. Recently he told NBC news ...Paradigm Press | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aerovate Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aerovate Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.